Perflenapent Completed Phase 1 Trials for Ischemic Stroke Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02963376A Phase Ib/II in Patients With Acute Ischemic Stroke